The Guardian
The Guardian
Ready to play
Ready to play
The article discusses hair loss as a side effect of GLP-1 receptor agonists used for weight loss and type 2 diabetes. Around 20% of users report hair shedding, primarily within the first year, with two main types observed: temporary telogen effluvium caused by stress or rapid weight loss, and less common, permanent pattern baldness linked to genetics. Factors such as drug dosage, rapid calorie restriction, and nutritional deficiencies contribute to temporary hair loss, which often resolves over time. Experts suggest discussing concerns with a doctor and maintaining good nutrition, while noting that the health benefits of GLP-1 drugs generally outweigh potential cosmetic issues.
Notice: This Is an AI-Generated Summary
Comments (0)